Clinical trial
Frequency and Effect on the Prognosis of Hyponatremia During the diagnosıs in Small Cell Lung Cancer
NCT04451460 is registered in ClinicalTrials.gov with Ankara City Hospital Bilkent as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Frequency and Effect on the Prognosis of Hyponatremia During the diagnosıs in Small Cell Lung Cancer
- Lead sponsor
- Ankara City Hospital Bilkent
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2012
- Completion date
- January 1, 2017
- Enrollment
- 466 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
small cell lung cancer